GFAP and myeloid sarcoma: Elevated CSF GFAP was associated with long-term MS disease progression according to a recent study [36] while Abdelhak et al. found a positive correlation between CSF GFAP with disease duration in patients with primary progressive MS [37], although GFAP level in serum reflected the disease activity better than CSF GFAP.